Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Centrally active adrenergic agents in development at Pierre Fabre

April 3, 1998

Neurogen prepares new class of brain GABA receptor ligands

April 3, 1998

Neurex completes patient enrollment in ziconotide phase III trial

April 2, 1998

Recent data suggest mechanism of action of nefiracetam's beneficial effects on cognition

April 2, 1998

Schering-Plough presents new agents for cognitive disorders

April 2, 1998

Effects of MKC-242 on cholinergic neurons examined using in vivo microdialysis

April 1, 1998

MCI-225: neurochemical profile of a novel antidepressant

April 1, 1998

OPC-24439, a new sigma-receptor ligand, suppresses hippocampal neuronal activity

April 1, 1998

Synthelabo claims compounds with selective affinity for certain GABA-A receptors

April 1, 1998

NOS inhibitors claimed by Schering AG for CNS disorders

April 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...